TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expression K.D. AmoilsW.R. Bezwoda OriginalPaper Pages: 95 - 101
Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells Rosella SilvestriniDaniela GornatiCinzia De Marco OriginalPaper Pages: 103 - 112
Macromolecular interstitial clearance, tumour vascularity, other prognostic factors and breast cancer survival Ernest E. SternsSandip SenGuptaBenny Zee OriginalPaper Pages: 113 - 120
Breast cancer stage at diagnosis: Caucasians versus Hispanics Arlene J. Zaloznik OriginalPaper Pages: 121 - 124
Inhibition of hormone and growth factor responsive and resistant human breast cancer cells by CeReS-18, a cell regulatory sialoglycopeptide Heideh K. FattaeyNatalie A. BetzTerry C. Johnson OriginalPaper Pages: 125 - 136
CeReS-18, a novel cell surface sialoglycopeptide, induces cell cycle arrest and apoptosis in a calcium-sensitive manner Natalie A. BetzHeideh K FattaeyTerry C. Johnson OriginalPaper Pages: 137 - 148
Validation of existing and development of new prognostic classification schemes in node negative breast cancer Willi SauerbreiKlaus HübnerMartin Schumacher OriginalPaper Pages: 149 - 163
Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma Peter B. VermeulenMartha LiburaLuc Y. Dirix OriginalPaper Pages: 165 - 172
Clinical significance of bcl-2 gene expression in human breast cancer tissues Shunzo KobayashiHirotaka IwaseAkira Masaoka OriginalPaper Pages: 173 - 181
Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer P. PronzatoP. QueiroloF. Cafiero OriginalPaper Pages: 183 - 186
Seasonal trends in the self-detection of breast cancer: indications from the Cancer and Steroid Hormone (CASH) study Julie A. RossRichard K. SeversonJohn D. Potter OriginalPaper Pages: 187 - 192